Early outcomes of a pilot study of neoadjuvant chemotherapy with S-1 plus oxaliplatin at dose of 130mg/m2 (nacG-SOX130) in stage III gastric cancer

Authors :: Ryuta Nishitai
H. An
T. Ota
K. Kawaguchi
Shinya Hamasu
Ryo Kudo
Dai Manaka
Y. Nishikawa
Sayuri Konishi
Source :: Annals of Oncology. 29:v18
Publication Year :: 2018
Publisher :: Elsevier BV, 2018.

Subjects :: Oncology
Chemotherapy
medicine.medical_specialty
business.industry
medicine.medical_treatment
Internal medicine
medicine
Stage III Gastric Cancer
Hematology
business
Oxaliplatin
medicine.drug

Full Text Access

Tools